{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:57:04Z","timestamp":1780631824334,"version":"3.54.1"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11011-022-00999-2","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T09:04:39Z","timestamp":1652173479000},"page":"2143-2161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Emerging targets signaling for inflammation in Parkinson\u2019s disease drug discovery"],"prefix":"10.1007","volume":"37","author":[{"given":"Rhema Chandan","family":"Khairnar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedar S.","family":"Prabhavalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh Kumar","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"999_CR1","doi-asserted-by":"publisher","DOI":"10.2174\/1871527316666170602101538","author":"AI Abushouk","year":"2017","unstructured":"Abushouk AI, Negida A, Elshenawy RA et al (2017) C-Abl Inhibition; A Novel Therapeutic Target for Parkinson\u2019s Disease. CNS Neurol Disord - Drug Targets. https:\/\/doi.org\/10.2174\/1871527316666170602101538","journal-title":"CNS Neurol Disord - Drug Targets"},{"key":"999_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","volume":"91","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Kwatra M, Ranjan Panda S et al (2021) Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease. Brain Behav Immun 91:142\u2013158. https:\/\/doi.org\/10.1016\/j.bbi.2020.09.017","journal-title":"Brain Behav Immun"},{"key":"999_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s13311-013-0218-1","volume":"11","author":"A AlDakheel","year":"2014","unstructured":"AlDakheel A, Kalia LV, Lang AE (2014) Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease. Neurotherapeutics 11:6\u201323. https:\/\/doi.org\/10.1007\/s13311-013-0218-1","journal-title":"Neurotherapeutics"},{"key":"999_CR4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85456","author":"S Brahmachari","year":"2016","unstructured":"Brahmachari S, Ge P, Lee SH et al (2016) Activation of tyrosine kinase c-Abl contributes to \u03b1-synuclein-induced neurodegeneration. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI85456","journal-title":"J Clin Invest"},{"key":"999_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3233\/JPD-171191","volume":"7","author":"S Brahmachari","year":"2017","unstructured":"Brahmachari S, Karuppagounder SS, Ge P et al (2017) c-Abl and Parkinson\u2019s Disease: Mechanisms and Therapeutic Potential. J Parkinsons Dis 7:589\u2013601. https:\/\/doi.org\/10.3233\/JPD-171191","journal-title":"J Parkinsons Dis"},{"key":"999_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/neu.10077","author":"F Brischoux","year":"2002","unstructured":"Brischoux F, Griffond B, Fellmann D, Risold PY (2002) Early and transient ontogenetic expression of the cocaine- and amphetamine-regulated transcript peptide in the rat mesencephalon: Correlation with tyrosine hydroxylase expression. J Neurobiol. https:\/\/doi.org\/10.1002\/neu.10077","journal-title":"J Neurobiol"},{"key":"999_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36470","author":"V Brochard","year":"2008","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A et al (2008) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI36470","journal-title":"J Clin Invest"},{"key":"999_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cellsig.2010.01.006","volume":"22","author":"I Carballo-Carbajal","year":"2010","unstructured":"Carballo-Carbajal I, Weber-Endress S, Rovelli G et al (2010) Leucine-rich repeat kinase 2 induces \u03b1-synuclein expression via the extracellular signal-regulated kinase pathway. Cell Signal 22:821\u2013827. https:\/\/doi.org\/10.1016\/j.cellsig.2010.01.006","journal-title":"Cell Signal"},{"key":"999_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.08.002","volume":"169","author":"Z Chen","year":"2018","unstructured":"Chen Z, Chen S, Liu J (2018) The role of T cells in the pathogenesis of Parkinson\u2019s disease. Prog Neurobiol 169:1\u201323. https:\/\/doi.org\/10.1016\/j.pneurobio.2018.08.002","journal-title":"Prog Neurobiol"},{"key":"999_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbr.2018.06.005","volume":"356","author":"L Chen","year":"2019","unstructured":"Chen L, Xue L, Zheng J et al (2019) PPAR\u00df\/\u03b4 agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson\u2019s disease. Behav Brain Res 356:483\u2013489. https:\/\/doi.org\/10.1016\/j.bbr.2018.06.005","journal-title":"Behav Brain Res"},{"key":"999_CR11","doi-asserted-by":"publisher","unstructured":"Chung KKK, Thomas B, Li X, et al (2004) S-nitrosylation of parkin regulates ubiquitination and compromises parkin\u2019s protective function. Science (80- ). https:\/\/doi.org\/10.1126\/science.1093891","DOI":"10.1126\/science.1093891"},{"key":"999_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055375","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T et al (2013) Triggering of Inflammasome by Aggregated \u03b1-Synuclein, an Inflammatory Response in Synucleinopathies. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0055375","journal-title":"PLoS ONE"},{"key":"999_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/22221751.2020.1720526","volume":"9","author":"H Cohen","year":"2020","unstructured":"Cohen H, Baram N, Edry-Botzer L et al (2020) Vibrio pore-forming leukocidin activates pyroptotic cell death via the NLRP3 inflammasome. Emerg Microbes Infect 9:278\u2013290. https:\/\/doi.org\/10.1080\/22221751.2020.1720526","journal-title":"Emerg Microbes Infect"},{"key":"999_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbrc.2008.11.048","volume":"378","author":"JP Covy","year":"2009","unstructured":"Covy JP, Giasson BI (2009) Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2. Biochem Biophys Res Commun 378:473\u2013477. https:\/\/doi.org\/10.1016\/j.bbrc.2008.11.048","journal-title":"Biochem Biophys Res Commun"},{"key":"999_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1172\/JCI42974","volume":"121","author":"G Cui","year":"2011","unstructured":"Cui G, Qin X, Wu L et al (2011) Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J Clin Invest 121:658\u2013670. https:\/\/doi.org\/10.1172\/JCI42974","journal-title":"J Clin Invest"},{"key":"999_CR16","unstructured":"Denali (2020) Denali press release 6 August 2020. https:\/\/www.denalitherapeutics.com\/investors\/press-release?id=7661"},{"key":"999_CR17","unstructured":"Denali (2021) Denali press release 8 January 2021. https:\/\/www.denalitherapeutics.com\/investors\/press-release?id=7881"},{"key":"999_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nchembio.538","volume":"7","author":"X Deng","year":"2011","unstructured":"Deng X, Dzamko N, Prescott A et al (2011) Characterization of a selective inhibitor of the Parkinson\u2019s disease kinase LRRK2. Nat Chem Biol 7:203\u2013205. https:\/\/doi.org\/10.1038\/nchembio.538","journal-title":"Nat Chem Biol"},{"key":"999_CR19","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.15-03-02471.1995","author":"J Douglass","year":"1995","unstructured":"Douglass J, McKinzie AA, Couceyro P (1995) PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci. https:\/\/doi.org\/10.1523\/jneurosci.15-03-02471.1995","journal-title":"J Neurosci"},{"key":"999_CR20","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1096\/fj.08-120410","volume":"23","author":"T Duka","year":"2009","unstructured":"Duka T, Duka V, Joyce JN, Sidhu A (2009) \u03b1-Synuclein contributes to GSK-3\u03b2-catalyzed Tau phosphorylation in Parkinson\u2019s disease models. FASEB J 23:2820\u20132830. https:\/\/doi.org\/10.1096\/fj.08-120410","journal-title":"FASEB J"},{"key":"999_CR21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1523\/JNEUROSCI.5092-10.2011","volume":"31","author":"J Dusonchet","year":"2011","unstructured":"Dusonchet J, Kochubey O, Stafa K et al (2011) A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson\u2019s Disease-Associated G2019S Mutation in LRRK2. J Neurosci 31:907\u2013912. https:\/\/doi.org\/10.1523\/JNEUROSCI.5092-10.2011","journal-title":"J Neurosci"},{"key":"999_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/BF01273357","volume":"103","author":"M Dziedzicka-Wasylewska","year":"1996","unstructured":"Dziedzicka-Wasylewska M, Ma\u0107kowiak M, Fija\u03c4 K, W\u0119dzony K (1996) Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. J Neural Transm 103:765\u2013776. https:\/\/doi.org\/10.1007\/BF01273357","journal-title":"J Neural Transm"},{"key":"999_CR23","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.neurobiolaging.2005.06.010","volume":"27","author":"T Engel","year":"2006","unstructured":"Engel T, Lucas JJ, G\u00f3mez-Ramos P et al (2006) Cooexpression of FTDP-17 tau and GSK-3\u03b2 in transgenic mice induce tau polymerization and neurodegeneration. Neurobiol Aging 27:1258\u20131268. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.06.010","journal-title":"Neurobiol Aging"},{"key":"999_CR24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1021\/jm401654j","volume":"57","author":"AA Estrada","year":"2014","unstructured":"Estrada AA, Chan BK, Baker-Glenn C et al (2014) Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors. J Med Chem 57:921\u2013936. https:\/\/doi.org\/10.1021\/jm401654j","journal-title":"J Med Chem"},{"key":"999_CR25","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"N Exner","year":"2012","unstructured":"Exner N, Lutz AK, Haass C, Winklhofer KF (2012) Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences. EMBO J 31:3038\u20133062. https:\/\/doi.org\/10.1038\/emboj.2012.170","journal-title":"EMBO J"},{"key":"999_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2007.05.027","author":"P Fagergren","year":"2007","unstructured":"Fagergren P, Hurd Y (2007) CART mRNA expression in rat monkey and human brain: Relevance to cocaine abuse. Physiol Behav. https:\/\/doi.org\/10.1016\/j.physbeh.2007.05.027","journal-title":"Physiol Behav"},{"key":"999_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12974-017-1036-x","volume":"14","author":"Z Fan","year":"2017","unstructured":"Fan Z, Liang Z, Yang H et al (2017) Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia. J Neuroinflammation 14:256. https:\/\/doi.org\/10.1186\/s12974-017-1036-x","journal-title":"J Neuroinflammation"},{"key":"999_CR28","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/mds.10270","volume":"17","author":"A Feigin","year":"2002","unstructured":"Feigin A, Antonini A, Fukuda M et al (2002) Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 17:1265\u20131270. https:\/\/doi.org\/10.1002\/mds.10270","journal-title":"Mov Disord"},{"key":"999_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrn.2017.39","volume":"18","author":"AJ Filiano","year":"2017","unstructured":"Filiano AJ, Gadani SP, Kipnis J (2017) How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci 18:375\u2013384. https:\/\/doi.org\/10.1038\/nrn.2017.39","journal-title":"Nat Rev Neurosci"},{"key":"999_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/0264-6021:3590001","volume":"359","author":"S Frame","year":"2001","unstructured":"Frame S, COHEN P, (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359:1. https:\/\/doi.org\/10.1042\/0264-6021:3590001","journal-title":"Biochem J"},{"key":"999_CR31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20150237","author":"L Freeman","year":"2017","unstructured":"Freeman L, Guo H, David CN et al (2017) NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20150237","journal-title":"J Exp Med"},{"key":"999_CR32","doi-asserted-by":"publisher","unstructured":"Fuji RN, Flagella M, Baca M et al (2015) Effect of selective LRRK2 kinase inhibition on nonhuman primate lung. Sci Transl Med 7. https:\/\/doi.org\/10.1126\/scitranslmed.aaa3634","DOI":"10.1126\/scitranslmed.aaa3634"},{"key":"999_CR33","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9:556\u2013567. https:\/\/doi.org\/10.1038\/nri2586","journal-title":"Nat Rev Immunol"},{"key":"999_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4161\/cam.4.1.10314","volume":"4","author":"SI Galkina","year":"2010","unstructured":"Galkina SI, Stadnichuk VI, Molotkovsky JG et al (2010) Microbial alkaloid staurosporine induces formation of nanometer-wide membrane tubular extensions (cytonemes, membrane tethers) in human neutrophils. Cell Adh Migr 4:32\u201338. https:\/\/doi.org\/10.4161\/cam.4.1.10314","journal-title":"Cell Adh Migr"},{"key":"999_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainresbull.2020.08.015","volume":"164","author":"M-R Gao","year":"2020","unstructured":"Gao M-R, Wang M, Jia Y-Y et al (2020) Echinacoside protects dopaminergic neurons by inhibiting NLRP3\/Caspase-1\/IL-1\u03b2 signaling pathway in MPTP-induced Parkinson\u2019s disease model. Brain Res Bull 164:55\u201364. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.08.015","journal-title":"Brain Res Bull"},{"key":"999_CR36","doi-asserted-by":"crossref","unstructured":"Goldfine A, Faulkner R, Sadashivam V, et al (2019) Results of a Phase 1 Dose-Ranging Trial, and Design of a Phase 2 Trial, of K0706, a Novel C-Abl Tyrosine Kinase Inhibitor for Parkinson\u2019s Disease. (P2.8\u2013047). Neurology 92:P2.8\u2013047","DOI":"10.1212\/WNL.92.15_supplement.P2.8-047"},{"key":"999_CR37","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.yexcr.2007.12.015","volume":"314","author":"F G\u00f6tschel","year":"2008","unstructured":"G\u00f6tschel F, Kern C, Lang S et al (2008) Inhibition of GSK3 differentially modulates NF-\u03baB, CREB, AP-1 and \u03b2-catenin signaling in hepatocytes, but fails to promote TNF-\u03b1-induced apoptosis. Exp Cell Res 314:1351\u20131366. https:\/\/doi.org\/10.1016\/j.yexcr.2007.12.015","journal-title":"Exp Cell Res"},{"key":"999_CR38","doi-asserted-by":"publisher","first-page":"e2858","DOI":"10.1038\/cddis.2017.250","volume":"8","author":"C Gu","year":"2017","unstructured":"Gu C, Zhang Y, Hu Q et al (2017) P7C3 inhibits GSK3\u03b2 activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo. Cell Death Dis 8:e2858\u2013e2858. https:\/\/doi.org\/10.1038\/cddis.2017.250","journal-title":"Cell Death Dis"},{"key":"999_CR39","doi-asserted-by":"publisher","unstructured":"Guaitoli G, Raimondi F, Gilsbach BK et al (2016) Structural model of the dimeric Parkinson\u2019s protein LRRK2 reveals a compact architecture involving distant interdomain contacts. Proc Natl Acad Sci 113. https:\/\/doi.org\/10.1073\/pnas.1523708113","DOI":"10.1073\/pnas.1523708113"},{"key":"999_CR40","doi-asserted-by":"crossref","unstructured":"Guan Y, Han F (2020) Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases. Front Integr Neurosci","DOI":"10.3389\/fnint.2020.00037"},{"key":"999_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00109-012-0984-y","volume":"91","author":"PS Guerreiro","year":"2013","unstructured":"Guerreiro PS, Huang Y, Gysbers A et al (2013) LRRK2 interactions with \u03b1-synuclein in Parkinson\u2019s disease brains and in cell models. J Mol Med 91:513\u2013522. https:\/\/doi.org\/10.1007\/s00109-012-0984-y","journal-title":"J Mol Med"},{"key":"999_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-018-0622-5","author":"G Gustafsson","year":"2018","unstructured":"Gustafsson G, L\u00f6\u00f6v C, Persson E et al (2018) Secretion and Uptake of \u03b1-Synuclein Via Extracellular Vesicles in Cultured Cells. Cell Mol Neurobiol. https:\/\/doi.org\/10.1007\/s10571-018-0622-5","journal-title":"Cell Mol Neurobiol"},{"key":"999_CR43","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","volume":"15","author":"X Han","year":"2019","unstructured":"Han X, Sun S, Sun Y et al (2019) Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease. Autophagy 15:1860\u20131881. https:\/\/doi.org\/10.1080\/15548627.2019.1596481","journal-title":"Autophagy"},{"key":"999_CR44","doi-asserted-by":"crossref","unstructured":"Hantschel O, Superti-Furga G (2004) Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat. Rev. Mol. Cell Biol.","DOI":"10.1240\/sav_gbm_2004_h_000820"},{"key":"999_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mds.27874","volume":"35","author":"ME Haque","year":"2020","unstructured":"Haque ME, Akther M, Jakaria M et al (2020) Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson\u2019s Disease. Mov Disord 35:20\u201333. https:\/\/doi.org\/10.1002\/mds.27874","journal-title":"Mov Disord"},{"key":"999_CR46","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","volume":"33","author":"AS Harms","year":"2013","unstructured":"Harms AS, Cao S, Rowse AL et al (2013) MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration. J Neurosci 33:9592\u20139600. https:\/\/doi.org\/10.1523\/JNEUROSCI.5610-12.2013","journal-title":"J Neurosci"},{"key":"999_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2963540","volume":"2020","author":"X He","year":"2020","unstructured":"He X, Zhou Y, Sheng S et al (2020) Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia. Oxid Med Cell Longev 2020:1\u201313. https:\/\/doi.org\/10.1155\/2020\/2963540","journal-title":"Oxid Med Cell Longev"},{"key":"999_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt192","author":"ML Hebron","year":"2013","unstructured":"Hebron ML, Lonskaya I, Moussa CEH (2013) Nilotinib reverses loss of dopamine neurons and improvesmotorbehavior via autophagic degradation of \u03b1-synuclein in parkinson\u2019s disease models. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddt192","journal-title":"Hum Mol Genet"},{"key":"999_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/nature11729","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A et al (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. https:\/\/doi.org\/10.1038\/nature11729","journal-title":"Nature"},{"key":"999_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2011.07.040","author":"CM Hostetler","year":"2011","unstructured":"Hostetler CM, Kowalczyk AS, Griffin LL, Bales KL (2011) CART peptide following social novelty in the prairie vole (Microtus ochrogaster). Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2011.07.040","journal-title":"Brain Res"},{"key":"999_CR51","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/j.1471-4159.2010.06568.x","volume":"112","author":"CH Hsu","year":"2010","unstructured":"Hsu CH, Chan D, Greggio E et al (2010a) MKK6 binds and regulates expression of Parkinson\u2019s disease-related protein LRRK2. J Neurochem 112:1593\u20131604. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06568.x","journal-title":"J Neurochem"},{"key":"999_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000285509","volume":"7","author":"CH Hsu","year":"2010","unstructured":"Hsu CH, Chan D, Wolozin B (2010b) LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins. Neurodegener Dis 7:68\u201375. https:\/\/doi.org\/10.1159\/000285509","journal-title":"Neurodegener Dis"},{"key":"999_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577543","volume":"354","author":"S Huang","year":"2021","unstructured":"Huang S, Chen Z, Fan B et al (2021a) A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson\u2019s disease. J Neuroimmunol 354:577543. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577543","journal-title":"J Neuroimmunol"},{"key":"999_CR54","doi-asserted-by":"publisher","unstructured":"Huang S, Liu H, Lin Y et al (2021b) Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson\u2019s Disease Model. Front Pharmacol 11. https:\/\/doi.org\/10.3389\/fphar.2020.618787","DOI":"10.3389\/fphar.2020.618787"},{"key":"999_CR55","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/1568007033482896","volume":"2","author":"R Hunter","year":"2003","unstructured":"Hunter R, Kuhar M (2003) CART Peptides as Targets for CNS Drug Development. Curr Drug Target -CNS Neurol Disord 2:201\u2013205. https:\/\/doi.org\/10.2174\/1568007033482896","journal-title":"Curr Drug Target -CNS Neurol Disord"},{"key":"999_CR56","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1833-10.2011","author":"SZ Imam","year":"2011","unstructured":"Imam SZ, Zhou Q, Yamamoto A et al (2011) Novel regulation of Parkin function through c-Abl-mediated tyrosine phosphorylation: Implications for Parkinson\u2019s disease. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.1833-10.2011","journal-title":"J Neurosci"},{"key":"999_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065129","volume":"8","author":"SZ Imam","year":"2013","unstructured":"Imam SZ, Trickler W, Kimura S et al (2013) Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson\u2019s Disease Model. PLoS ONE 8:e65129. https:\/\/doi.org\/10.1371\/journal.pone.0065129","journal-title":"PLoS ONE"},{"key":"999_CR58","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3390\/cells9122565","volume":"9","author":"GR Jeong","year":"2020","unstructured":"Jeong GR, Lee BD (2020) Pathological Functions of LRRK2 in Parkinson\u2019s Disease. Cells 9:2565. https:\/\/doi.org\/10.3390\/cells9122565","journal-title":"Cells"},{"key":"999_CR59","doi-asserted-by":"publisher","unstructured":"Jiang W, Huang Y, He F, et al (2016) Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation, controls inflammation, and alleviates histopathology in a rat model of spinal cord injury. Spine (Phila Pa 1976). https:\/\/doi.org\/10.1097\/BRS.0000000000001287","DOI":"10.1097\/BRS.0000000000001287"},{"key":"999_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","volume":"29","author":"RS Jope","year":"2004","unstructured":"Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95\u2013102. https:\/\/doi.org\/10.1016\/j.tibs.2003.12.004","journal-title":"Trends Biochem Sci"},{"key":"999_CR61","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","volume":"93","author":"PS Klein","year":"1996","unstructured":"Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci 93:8455\u20138459. https:\/\/doi.org\/10.1073\/pnas.93.16.8455","journal-title":"Proc Natl Acad Sci"},{"key":"999_CR62","doi-asserted-by":"publisher","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s Disease. Cold Spring Harb Perspect Med 2:a008888\u2013a008888. https:\/\/doi.org\/10.1101\/cshperspect.a008888","journal-title":"Cold Spring Harb Perspect Med"},{"key":"999_CR63","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1084\/jem.20082771","volume":"206","author":"L Klotz","year":"2009","unstructured":"Klotz L, Burgdorf S, Dani I et al (2009) The nuclear receptor PPAR\u03b3 selectively inhibits Th17 differentiation in a T cell\u2013intrinsic fashion and suppresses CNS autoimmunity. J Exp Med 206:2079\u20132089. https:\/\/doi.org\/10.1084\/jem.20082771","journal-title":"J Exp Med"},{"key":"999_CR64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1006083107","author":"HS Ko","year":"2010","unstructured":"Ko HS, Lee Y, Shin JH et al (2010) Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin\u2019s ubiquitination and protective function. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.1006083107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"999_CR65","doi-asserted-by":"publisher","unstructured":"Kondo K, Obitsu S, Teshima R (2011) .ALPHA.-Synuclein Aggregation and Transmission Are Enhanced by Leucine-Rich Repeat Kinase 2 in Human Neuroblastoma SH-SY5Y Cells. Biol Pharm Bull 34:1078\u20131083. https:\/\/doi.org\/10.1248\/bpb.34.1078","DOI":"10.1248\/bpb.34.1078"},{"key":"999_CR66","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2826.1997.00651.x","author":"EO Koylu","year":"1997","unstructured":"Koylu EO, Couceyro PR, Lambert PD et al (1997) Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol. https:\/\/doi.org\/10.1046\/j.1365-2826.1997.00651.x","journal-title":"J Neuroendocrinol"},{"key":"999_CR67","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/cmdc.200500039","volume":"1","author":"AP Kozikowski","year":"2006","unstructured":"Kozikowski AP, Gaisina IN, Petukhov PA et al (2006) Highly Potent and Specific GSK-3\u03b2 Inhibitors That Block Tau Phosphorylation and Decrease \u03b1-Synuclein Protein Expression in a Cellular Model of Parkinson\u2019s Disease. ChemMedChem 1:256\u2013266. https:\/\/doi.org\/10.1002\/cmdc.200500039","journal-title":"ChemMedChem"},{"key":"999_CR68","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.1111\/j.1742-4658.2009.07344.x","volume":"276","author":"U Kumari","year":"2009","unstructured":"Kumari U, Tan EK (2009) LRRK2 in Parkinson\u2019s disease: genetic and clinical studies from patients. FEBS J 276:6455\u20136463. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.07344.x","journal-title":"FEBS J"},{"key":"999_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2013.04.016","author":"E Kuric","year":"2013","unstructured":"Kuric E, Wieloch T, Ruscher K (2013) Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2013.04.016","journal-title":"Exp Neurol"},{"key":"999_CR70","doi-asserted-by":"publisher","first-page":"15091","DOI":"10.1021\/acs.jmedchem.1c01022","volume":"64","author":"S-H Kwon","year":"2021","unstructured":"Kwon S-H, Kim S, Park AY et al (2021) A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson\u2019s Disease. J Med Chem 64:15091\u201315110. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01022","journal-title":"J Med Chem"},{"key":"999_CR71","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston JW, Forno LS, Tetrud J et al (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598\u2013605. https:\/\/doi.org\/10.1002\/1531-8249(199910)46:4%3c598::AID-ANA7%3e3.0.CO;2-F","journal-title":"Ann Neurol"},{"key":"999_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/nature14893","author":"M Lazarou","year":"2015","unstructured":"Lazarou M, Sliter DA, Kane LA et al (2015) The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. https:\/\/doi.org\/10.1038\/nature14893","journal-title":"Nature"},{"key":"999_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3500","author":"Y Lee","year":"2013","unstructured":"Lee Y, Karuppagounder SS, Shin JH et al (2013) Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat Neurosci. https:\/\/doi.org\/10.1038\/nn.3500","journal-title":"Nat Neurosci"},{"key":"999_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.090","author":"Y Lee","year":"2017","unstructured":"Lee Y, Stevens DA, Kang SU et al (2017) PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.090","journal-title":"Cell Rep"},{"key":"999_CR75","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1093\/hmg\/ddy143","volume":"27","author":"S Lee","year":"2018","unstructured":"Lee S, Kim S, Park YJ et al (2018) The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson\u2019s disease mouse model. Hum Mol Genet 27:2344\u20132356. https:\/\/doi.org\/10.1093\/hmg\/ddy143","journal-title":"Hum Mol Genet"},{"key":"999_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-018-0124-5","author":"E Lee","year":"2019","unstructured":"Lee E, Hwang I, Park S et al (2019) MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-018-0124-5","journal-title":"Cell Death Differ"},{"key":"999_CR77","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4062\/biomolther.2021.039","volume":"29","author":"Y-H Leem","year":"2021","unstructured":"Leem Y-H, Park J-S, Park J-E et al (2021) Papaverine Exerts Neuroprotective Effect by Inhibiting NLRP3 Inflammasome Activation in an MPTP-Induced Microglial Priming Mouse Model Challenged with LPS. Biomol Ther (seoul) 29:295\u2013302. https:\/\/doi.org\/10.4062\/biomolther.2021.039","journal-title":"Biomol Ther (seoul)"},{"key":"999_CR78","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3892\/mmr.2014.2080","volume":"9","author":"D-W Li","year":"2014","unstructured":"Li D-W, Liu Z-Q, Wei-Chen, et al (2014) Association of glycogen synthase kinase-3\u03b2 with Parkinson\u2019s disease (Review). Mol Med Rep 9:2043\u20132050. https:\/\/doi.org\/10.3892\/mmr.2014.2080","journal-title":"Mol Med Rep"},{"key":"999_CR79","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","volume":"31","author":"D Li","year":"2018","unstructured":"Li D, Yang H, Ma J et al (2018a) MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3. Hum Cell 31:106\u2013115. https:\/\/doi.org\/10.1007\/s13577-017-0187-5","journal-title":"Hum Cell"},{"key":"999_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2018.03.002","author":"R Li","year":"2018","unstructured":"Li R, Wang J, Li R et al (2018b) ATP\/P2X7-NLRP3 axis of dendritic cells participates in the regulation of airway inflammation and hyper-responsiveness in asthma by mediating HMGB1 expression and secretion. Exp Cell Res. https:\/\/doi.org\/10.1016\/j.yexcr.2018.03.002","journal-title":"Exp Cell Res"},{"key":"999_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37584-6","author":"X Li","year":"2019","unstructured":"Li X, Dong C, Hoffmann M et al (2019) Early stages of aggregation of engineered \u03b1-synuclein monomers and oligomers in solution. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-018-37584-6","journal-title":"Sci Rep"},{"key":"999_CR82","doi-asserted-by":"publisher","unstructured":"Li J, Ma S, Chen J et al (2020) GSK-3\u03b2 Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib. Front Mol Neurosci 13. https:\/\/doi.org\/10.3389\/fnmol.2020.00081","DOI":"10.3389\/fnmol.2020.00081"},{"key":"999_CR83","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","volume":"64","author":"X Lin","year":"2009","unstructured":"Lin X, Parisiadou L, Gu X-L et al (2009) Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson\u2019s-Disease-Related Mutant \u03b1-synuclein. Neuron 64:807\u2013827. https:\/\/doi.org\/10.1016\/j.neuron.2009.11.006","journal-title":"Neuron"},{"key":"999_CR84","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn CS, Dhanwani R, Pham J et al (2020) \u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun 11:1875. https:\/\/doi.org\/10.1038\/s41467-020-15626-w","journal-title":"Nat Commun"},{"key":"999_CR85","doi-asserted-by":"publisher","unstructured":"Lindholm D, Pham DD, Cascone A et al (2016) c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson\u2019s Disease. Front Aging Neurosci 8. https:\/\/doi.org\/10.3389\/fnagi.2016.00254","DOI":"10.3389\/fnagi.2016.00254"},{"key":"999_CR86","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1007\/s12035-016-0249-9","volume":"54","author":"Z Liu","year":"2017","unstructured":"Liu Z, Huang Y, Cao B-B et al (2017a) Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1\/ICAM-1 Interaction in a Mouse Model of Parkinson\u2019s Disease. Mol Neurobiol 54:7762\u20137776. https:\/\/doi.org\/10.1007\/s12035-016-0249-9","journal-title":"Mol Neurobiol"},{"key":"999_CR87","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0249-9","author":"Z Liu","year":"2017","unstructured":"Liu Z, Huang Y, Cao BB et al (2017b) Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1\/ICAM-1 Interaction in a Mouse Model of Parkinson\u2019s Disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-016-0249-9","journal-title":"Mol Neurobiol"},{"key":"999_CR88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-017-0426-8","volume":"5","author":"F Longo","year":"2017","unstructured":"Longo F, Mercatelli D, Novello S et al (2017) Age-dependent dopamine transporter dysfunction and Serine129 phospho-\u03b1-synuclein overload in G2019S LRRK2 mice. Acta Neuropathol Commun 5:22. https:\/\/doi.org\/10.1186\/s40478-017-0426-8","journal-title":"Acta Neuropathol Commun"},{"key":"999_CR89","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12868-016-0315-2","volume":"17","author":"T Maekawa","year":"2016","unstructured":"Maekawa T, Sasaoka T, Azuma S et al (2016) Leucine-rich repeat kinase 2 (LRRK2) regulates \u03b1-synuclein clearance in microglia. BMC Neurosci 17:77. https:\/\/doi.org\/10.1186\/s12868-016-0315-2","journal-title":"BMC Neurosci"},{"key":"999_CR90","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt674","author":"AL Mahul-Mellier","year":"2014","unstructured":"Mahul-Mellier AL, Fauvet B, Gysbers A et al (2014) C-Abl phosphorylates \u03b1-synuclein and regulates its degradation: Implication for \u03b1-synuclein clearance and contribution to the pathogenesis of parkinson\u2019s disease. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddt674","journal-title":"Hum Mol Genet"},{"key":"999_CR91","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","volume":"28","author":"C Malagelada","year":"2008","unstructured":"Malagelada C, Jin ZH, Greene LA (2008) RTP801 Is Induced in Parkinson\u2019s Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation\/Activation. J Neurosci 28:14363\u201314371. https:\/\/doi.org\/10.1523\/JNEUROSCI.3928-08.2008","journal-title":"J Neurosci"},{"key":"999_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/762139","volume":"2011","author":"P Mao","year":"2011","unstructured":"Mao P (2011) Potential Antidepressant Role of Neurotransmitter CART: Implications for Mental Disorders. Depress Res Treat 2011:1\u201311. https:\/\/doi.org\/10.1155\/2011\/762139","journal-title":"Depress Res Treat"},{"key":"999_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029343","author":"P Mao","year":"2012","unstructured":"Mao P, Meshul CK, Thuillier P et al (2012) CART peptide is a potential endogenous antioxidant and preferentially localized in mitochondria. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0029343","journal-title":"PLoS ONE"},{"key":"999_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ph6010108","author":"P Mao","year":"2013","unstructured":"Mao P, Meshul CK, Thuillier P, Reddy PH (2013) Neurotransmitter CART as a new therapeutic candidate for Parkinson\u2019s disease. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph6010108","journal-title":"Pharmaceuticals"},{"key":"999_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-017-2185-0","author":"Z Mao","year":"2017","unstructured":"Mao Z, Liu C, Ji S et al (2017) The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson\u2019s Disease in Rats. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-017-2185-0","journal-title":"Neurochem Res"},{"key":"999_CR96","doi-asserted-by":"publisher","unstructured":"Massimino M, Stella S, Tirr\u00f2 E, et al (2020) ABL1-directed inhibitors for CML: efficacy, resistance and future perspectives. Anticancer Res 40:2457\u20132465. https:\/\/doi.org\/10.21873\/anticanres.14215","DOI":"10.21873\/anticanres.14215"},{"key":"999_CR97","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","volume":"166","author":"D Matheoud","year":"2016","unstructured":"Matheoud D, Sugiura A, Bellemare-Pelletier A et al (2016) Parkinson\u2019s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation. Cell 166:314\u2013327. https:\/\/doi.org\/10.1016\/j.cell.2016.05.039","journal-title":"Cell"},{"key":"999_CR98","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3233\/JPD-219006","volume":"11","author":"K McFarthing","year":"2021","unstructured":"McFarthing K, Rafaloff G, Baptista MAS et al (2021) Parkinson\u2019s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update. J Parkinsons Dis 11:891\u2013903. https:\/\/doi.org\/10.3233\/JPD-219006","journal-title":"J Parkinsons Dis"},{"key":"999_CR99","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/ijms17091585","volume":"17","author":"S Mehdi","year":"2016","unstructured":"Mehdi S, Rosas-Hernandez H, Cuevas E et al (2016) Protein Kinases and Parkinson\u2019s Disease. Int J Mol Sci 17:1585. https:\/\/doi.org\/10.3390\/ijms17091585","journal-title":"Int J Mol Sci"},{"key":"999_CR100","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","volume":"87","author":"F Moisan","year":"2016","unstructured":"Moisan F, Kab S, Mohamed F et al (2016) Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry 87:952\u2013957. https:\/\/doi.org\/10.1136\/jnnp-2015-312283","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"999_CR101","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1074\/jbc.M112.429936","volume":"288","author":"SF Moore","year":"2013","unstructured":"Moore SF, van den Bosch MTJ, Hunter RW et al (2013) Dual Regulation of Glycogen Synthase Kinase 3 (GSK3)\u03b1\/\u03b2 by Protein Kinase C (PKC)\u03b1 and Akt Promotes Thrombin-mediated Integrin \u03b1IIb\u03b23 Activation and Granule Secretion in Platelets. J Biol Chem 288:3918\u20133928. https:\/\/doi.org\/10.1074\/jbc.M112.429936","journal-title":"J Biol Chem"},{"key":"999_CR102","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1432-05.2005","author":"EMY Moresco","year":"2005","unstructured":"Moresco EMY, Donaldson S, Williamson A, Koleske AJ (2005) Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.1432-05.2005","journal-title":"J Neurosci"},{"key":"999_CR103","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00401-005-1087-4","volume":"110","author":"H Nakashima","year":"2005","unstructured":"Nakashima H, Ishihara T, Suguimoto P et al (2005) Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies. Acta Neuropathol 110:547\u2013556. https:\/\/doi.org\/10.1007\/s00401-005-1087-4","journal-title":"Acta Neuropathol"},{"key":"999_CR104","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1515\/revneuro-2018-0105","volume":"30","author":"A Nasrolahi","year":"2019","unstructured":"Nasrolahi A, Safari F, Farhoudi M et al (2019) Immune system and new avenues in Parkinson\u2019s disease research and treatment. Rev Neurosci 30:709\u2013727. https:\/\/doi.org\/10.1515\/revneuro-2018-0105","journal-title":"Rev Neurosci"},{"key":"999_CR105","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2013.02.024","volume":"541","author":"K Nie","year":"2013","unstructured":"Nie K, Zhang Y, Gan R et al (2013) Polymorphisms in immune\/inflammatory cytokine genes are related to Parkinson\u2019s disease with cognitive impairment in the Han Chinese population. Neurosci Lett 541:111\u2013115. https:\/\/doi.org\/10.1016\/j.neulet.2013.02.024","journal-title":"Neurosci Lett"},{"key":"999_CR106","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2174\/1570159X18666200814180218","volume":"19","author":"L Nie","year":"2021","unstructured":"Nie L, Ye W-R, Chen S et al (2021) Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain. Curr Neuropharmacol 19:665\u2013678. https:\/\/doi.org\/10.2174\/1570159X18666200814180218","journal-title":"Curr Neuropharmacol"},{"key":"999_CR107","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s12035-020-02198-5","volume":"58","author":"Z Ou","year":"2021","unstructured":"Ou Z, Zhou Y, Wang L et al (2021) NLRP3 Inflammasome Inhibition Prevents \u03b1-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP\u2013Treated NLRP3 Knockout Mice. Mol Neurobiol 58:1303\u20131311. https:\/\/doi.org\/10.1007\/s12035-020-02198-5","journal-title":"Mol Neurobiol"},{"key":"999_CR108","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182191","author":"N Panicker","year":"2019","unstructured":"Panicker N, Sarkar S, Harischandra DS et al (2019) Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20182191","journal-title":"J Exp Med"},{"key":"999_CR109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11011-020-00636-w","volume":"36","author":"T Pingale","year":"2021","unstructured":"Pingale T, Gupta GL (2021) Current and emerging therapeutic targets for Parkinson\u2019s disease. Metab Brain Dis 36:13\u201327. https:\/\/doi.org\/10.1007\/s11011-020-00636-w","journal-title":"Metab Brain Dis"},{"key":"999_CR110","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/biom10060912","volume":"10","author":"A Polissidis","year":"2020","unstructured":"Polissidis A, Petropoulou-Vathi L, Nakos-Bimpos M, Rideout HJ (2020) The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson\u2019s Disease. Biomolecules 10:912. https:\/\/doi.org\/10.3390\/biom10060912","journal-title":"Biomolecules"},{"key":"999_CR111","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/ph14080717","volume":"14","author":"EM Prasad","year":"2021","unstructured":"Prasad EM, Hung S-Y (2021) Current Therapies in Clinical Trials of Parkinson\u2019s Disease: A 2021 Update. Pharmaceuticals 14:717. https:\/\/doi.org\/10.3390\/ph14080717","journal-title":"Pharmaceuticals"},{"key":"999_CR112","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2019.1590336","author":"I Prots","year":"2019","unstructured":"Prots I, Winner B (2019) Th17 cells: a promising therapeutic target for Parkinson\u2019s disease? Expert Opin Ther Targets. https:\/\/doi.org\/10.1080\/14728222.2019.1590336","journal-title":"Expert Opin Ther Targets"},{"key":"999_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2012.02.045","author":"Y Qiao","year":"2012","unstructured":"Qiao Y, Wang P, Qi J et al (2012) TLR-induced NF-\u03baB activation regulates NLRP3 expression in murine macrophages. FEBS Lett. https:\/\/doi.org\/10.1016\/j.febslet.2012.02.045","journal-title":"FEBS Lett"},{"key":"999_CR114","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-9980-5","author":"C Qiao","year":"2017","unstructured":"Qiao C, Zhang LX, Sun XY et al (2017) Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7\/AIF Pathway in MPTP\/p Mouse Model of Parkinson\u2019s Disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-016-9980-5","journal-title":"Mol Neurobiol"},{"key":"999_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1236-z","author":"C Qiao","year":"2018","unstructured":"Qiao C, Zhang Q, Jiang Q et al (2018) Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP\/p mouse model of Parkinson\u2019s disease. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-018-1236-z","journal-title":"J Neuroinflammation"},{"key":"999_CR116","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbrc.2009.06.142","volume":"387","author":"H Qing","year":"2009","unstructured":"Qing H, Wong W, McGeer EG, McGeer PL (2009) Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. Biochem Biophys Res Commun 387:149\u2013152. https:\/\/doi.org\/10.1016\/j.bbrc.2009.06.142","journal-title":"Biochem Biophys Res Commun"},{"key":"999_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2021.05.008","volume":"349","author":"X Qiu","year":"2021","unstructured":"Qiu X, Wang Q, Hou L et al (2021) Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson\u2019s disease model. Toxicol Lett 349:1\u201311. https:\/\/doi.org\/10.1016\/j.toxlet.2021.05.008","journal-title":"Toxicol Lett"},{"key":"999_CR118","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1021\/cb2002413","volume":"6","author":"N Ramsden","year":"2011","unstructured":"Ramsden N, Perrin J, Ren Z et al (2011) Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson\u2019s Disease-Related Toxicity in Human Neurons. ACS Chem Biol 6:1021\u20131028. https:\/\/doi.org\/10.1021\/cb2002413","journal-title":"ACS Chem Biol"},{"key":"999_CR119","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1021\/acschemneuro.8b00180","volume":"10","author":"P Rane","year":"2019","unstructured":"Rane P, Sarmah D, Bhute S et al (2019) Novel Targets for Parkinson\u2019s Disease: Addressing Different Therapeutic Paradigms and Conundrums. ACS Chem Neurosci 10:44\u201357. https:\/\/doi.org\/10.1021\/acschemneuro.8b00180","journal-title":"ACS Chem Neurosci"},{"key":"999_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2008.07.003","author":"M Reale","year":"2009","unstructured":"Reale M, Iarlori C, Thomas A et al (2009) Peripheral cytokines profile in Parkinson\u2019s disease. Brain Behav Immun. https:\/\/doi.org\/10.1016\/j.bbi.2008.07.003","journal-title":"Brain Behav Immun"},{"key":"999_CR121","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","volume":"184","author":"AD Reynolds","year":"2010","unstructured":"Reynolds AD, Stone DK, Hutter JAL et al (2010) Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson\u2019s Disease. J Immunol 184:2261\u20132271. https:\/\/doi.org\/10.4049\/jimmunol.0901852","journal-title":"J Immunol"},{"key":"999_CR122","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nrn2493","volume":"9","author":"G Rogge","year":"2008","unstructured":"Rogge G, Jones D, Hubert GW et al (2008) CART peptides: regulators of body weight, reward and other functions. Nat Rev Neurosci 9:747\u2013758. https:\/\/doi.org\/10.1038\/nrn2493","journal-title":"Nat Rev Neurosci"},{"key":"999_CR123","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/ijnp\/pyaa060","volume":"23","author":"W Rui","year":"2020","unstructured":"Rui W, Li S, Xiao H et al (2020) Baicalein Attenuates Neuroinflammation by Inhibiting NLRP3\/Caspase-1\/GSDMD Pathway in MPTP-Induced Mice Model of Parkinson\u2019s Disease. Int J Neuropsychopharmacol 23:762\u2013773. https:\/\/doi.org\/10.1093\/ijnp\/pyaa060","journal-title":"Int J Neuropsychopharmacol"},{"key":"999_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.010","author":"JH Shin","year":"2011","unstructured":"Shin JH, Ko HS, Kang H et al (2011) PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in parkinson\u2019s disease. Cell. https:\/\/doi.org\/10.1016\/j.cell.2011.02.010","journal-title":"Cell"},{"key":"999_CR125","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/JAMANEUROL.2020.4725","volume":"78","author":"T Simuni","year":"2021","unstructured":"Simuni T, Fiske B, Merchant K et al (2021) Efficacy of Nilotinib in Patients with Moderately Advanced Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol 78:312\u2013320. https:\/\/doi.org\/10.1001\/JAMANEUROL.2020.4725","journal-title":"JAMA Neurol"},{"key":"999_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.06.015","author":"A Sommer","year":"2018","unstructured":"Sommer A, Maxreiter F, Krach F et al (2018) Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson\u2019s Disease. Cell Stem Cell. https:\/\/doi.org\/10.1016\/j.stem.2018.06.015","journal-title":"Cell Stem Cell"},{"key":"999_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-018-0024-z","author":"Y Song","year":"2018","unstructured":"Song Y, Na HS, Park E et al (2018) Streptococcus mutans activates the AIM2, NLRP3 and NLRC4 inflammasomes in human THP-1 macrophages. Int J Oral Sci. https:\/\/doi.org\/10.1038\/s41368-018-0024-z","journal-title":"Int J Oral Sci"},{"key":"999_CR128","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbi.2013.01.080","volume":"30","author":"L Souza-Moreira","year":"2013","unstructured":"Souza-Moreira L, Delgado-Maroto V, Morell M et al (2013) Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1\/Th17 responses and inducing regulatory T cells. Brain Behav Immun 30:54\u201360. https:\/\/doi.org\/10.1016\/j.bbi.2013.01.080","journal-title":"Brain Behav Immun"},{"key":"999_CR129","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F et al (2017) T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature 546:656\u2013661. https:\/\/doi.org\/10.1038\/nature22815","journal-title":"Nature"},{"key":"999_CR130","doi-asserted-by":"publisher","unstructured":"Tanabe A, Yamamura Y, Kasahara J et al (2014) A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson\u2019s disease. Front Cell Neurosci 8. https:\/\/doi.org\/10.3389\/fncel.2014.00050","DOI":"10.3389\/fncel.2014.00050"},{"key":"999_CR131","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.6.2722","author":"L Thim","year":"1999","unstructured":"Thim L, Kristensen P, Nielsen PF et al (1999) Tissue-specific processing of cocaine- and amphetamine-regulated transcript peptides in the rat. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.96.6.2722","journal-title":"Proc Natl Acad Sci U S A"},{"key":"999_CR132","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1016\/j.bmcl.2013.05.054","volume":"23","author":"T Troxler","year":"2013","unstructured":"Troxler T, Greenidge P, Zimmermann K et al (2013) Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2. Bioorg Med Chem Lett 23:4085\u20134090. https:\/\/doi.org\/10.1016\/j.bmcl.2013.05.054","journal-title":"Bioorg Med Chem Lett"},{"key":"999_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.12.004","author":"MA Upadhya","year":"2012","unstructured":"Upadhya MA, Nakhate KT, Kokare DM et al (2012) CART peptide in the nucleus accumbens shell acts downstream to dopamine and mediates the reward and reinforcement actions of morphine. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.004","journal-title":"Neuropharmacology"},{"key":"999_CR134","doi-asserted-by":"publisher","unstructured":"Voet S, Srinivasan S, Lamkanfi M, Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201810248","DOI":"10.15252\/emmm.201810248"},{"key":"999_CR135","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","volume":"36","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley LA, Abdelmotilib H, Liu Z et al (2016) G2019S-LRRK2 Expression Augments -Synuclein Sequestration into Inclusions in Neurons. J Neurosci 36:7415\u20137427. https:\/\/doi.org\/10.1523\/JNEUROSCI.3642-15.2016","journal-title":"J Neurosci"},{"key":"999_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2017.08.001","author":"B Wang","year":"2017","unstructured":"Wang B, Yin Q (2017) AIM2 inflammasome activation and regulation: A structural perspective. J Struct Biol. https:\/\/doi.org\/10.1016\/j.jsb.2017.08.001","journal-title":"J Struct Biol"},{"key":"999_CR137","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.4049\/jimmunol.1002513","volume":"186","author":"H Wang","year":"2011","unstructured":"Wang H, Brown J, Gu Z et al (2011) Convergence of the Mammalian Target of Rapamycin Complex 1- and Glycogen Synthase Kinase 3-\u03b2\u2013Signaling Pathways Regulates the Innate Inflammatory Response. J Immunol 186:5217\u20135226. https:\/\/doi.org\/10.4049\/jimmunol.1002513","journal-title":"J Immunol"},{"key":"999_CR138","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1610099113","author":"W Wang","year":"2016","unstructured":"Wang W, Nguyen LTT, Burlak C et al (2016) Caspase-1 causes truncation and aggregation of the Parkinson\u2019s disease-associated protein \u03b1-synuclein. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.1610099113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"999_CR139","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.8297","author":"X Wang","year":"2019","unstructured":"Wang X, Chi J, Huang D et al (2019) \u03b1-synuclein promotes progression of Parkinson\u2019s disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome. Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2019.8297","journal-title":"Exp Ther Med"},{"key":"999_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105254","volume":"152","author":"K Wang","year":"2022","unstructured":"Wang K, Lu C, Wang T et al (2022) Hyperoside suppresses NLRP3 inflammasome in Parkinson\u2019s disease via Pituitary Adenylate Cyclase-Activating Polypeptide. Neurochem Int 152:105254. https:\/\/doi.org\/10.1016\/j.neuint.2021.105254","journal-title":"Neurochem Int"},{"key":"999_CR141","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/978-3-211-45295-0_69","volume-title":"Parkinson\u2019s Disease and Related Disorders","author":"O Weinreb","year":"2006","unstructured":"Weinreb O, Amit T, Bar-Am O et al (2006) Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety. Parkinson\u2019s Disease and Related Disorders. Springer Vienna, Vienna, pp 457\u2013465"},{"key":"999_CR142","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3390\/biom11081101","volume":"11","author":"DN Wojewska","year":"2021","unstructured":"Wojewska DN, Kortholt A (2021) LRRK2 Targeting Strategies as Potential Treatment of Parkinson\u2019s Disease. Biomolecules 11:1101. https:\/\/doi.org\/10.3390\/biom11081101","journal-title":"Biomolecules"},{"key":"999_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.135","author":"R Wu","year":"2016","unstructured":"Wu R, Chen H, Ma J et al (2016) C-Abl-p38\u03b1 signaling plays an important role in MPTP-induced neuronal death. Cell Death Differ. https:\/\/doi.org\/10.1038\/cdd.2015.135","journal-title":"Cell Death Differ"},{"key":"999_CR144","doi-asserted-by":"publisher","unstructured":"Xiang H, Zhu F, Xu Z, Xiong J (2020) Role of Inflammasomes in Kidney Diseases via Both Canonical and Non-canonical Pathways. Front Cell Dev Biol 8. https:\/\/doi.org\/10.3389\/fcell.2020.00106","DOI":"10.3389\/fcell.2020.00106"},{"key":"999_CR145","doi-asserted-by":"publisher","first-page":"14489","DOI":"10.1073\/pnas.0602932103","volume":"103","author":"Y Xu","year":"2006","unstructured":"Xu Y, Zhang W, Klaus J et al (2006) Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection. Proc Natl Acad Sci 103:14489\u201314494. https:\/\/doi.org\/10.1073\/pnas.0602932103","journal-title":"Proc Natl Acad Sci"},{"key":"999_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0241-0","author":"K Yamada","year":"2018","unstructured":"Yamada K, Iwatsubo T (2018) Extracellular \u03b1-synuclein levels are regulated by neuronal activity. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-018-0241-0","journal-title":"Mol Neurodegener"},{"key":"999_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.11.047","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L et al (2015) Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. https:\/\/doi.org\/10.1016\/j.cell.2014.11.047","journal-title":"Cell"},{"key":"999_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.05.036","volume":"75","author":"C Yang","year":"2019","unstructured":"Yang C, Mo Y, Xu E et al (2019) Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson\u2019s disease mouse model. Int Immunopharmacol 75:105651. https:\/\/doi.org\/10.1016\/j.intimp.2019.05.036","journal-title":"Int Immunopharmacol"},{"key":"999_CR149","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0812","author":"T Yanik","year":"2006","unstructured":"Yanik T, Dominguez G, Kuhar MJ et al (2006) The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: A possible cause for obesity in humans. Endocrinology. https:\/\/doi.org\/10.1210\/en.2005-0812","journal-title":"Endocrinology"},{"key":"999_CR150","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404161101","author":"D Yao","year":"2004","unstructured":"Yao D, Gu Z, Nakamura T et al (2004) Nitrosative stress linked to sporadic Parkinson\u2019s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.0404161101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"999_CR151","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s11481-019-09843-4","volume":"14","author":"S Yao","year":"2019","unstructured":"Yao S, Li L, Sun X et al (2019) FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation. J Neuroimmune Pharmacol 14:478\u2013492. https:\/\/doi.org\/10.1007\/s11481-019-09843-4","journal-title":"J Neuroimmune Pharmacol"},{"key":"999_CR152","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10571-007-9185-6","volume":"28","author":"Y Yuan","year":"2008","unstructured":"Yuan Y, Jin J, Yang B et al (2008) Overexpressed Alpha-Synuclein Regulated the Nuclear Factor-kappaB Signal Pathway. Cell Mol Neurobiol 28:21\u201333. https:\/\/doi.org\/10.1007\/s10571-007-9185-6","journal-title":"Cell Mol Neurobiol"},{"key":"999_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/629507","volume":"2014","author":"H Zhang","year":"2014","unstructured":"Zhang H, Wang W, Fang H et al (2014) GSK-3 \u03b2 Inhibition Attenuates CLP-Induced Liver Injury by Reducing Inflammation and Hepatic Cell Apoptosis. Mediators Inflamm 2014:1\u201310. https:\/\/doi.org\/10.1155\/2014\/629507","journal-title":"Mediators Inflamm"},{"key":"999_CR154","doi-asserted-by":"publisher","unstructured":"Zhang X, Zhang Y, Li R, et al (2020) Salidroside ameliorates Parkinson\u2019s disease by inhibiting NLRP3-dependent pyroptosis. Aging (Albany NY) 12:9405\u20139426. https:\/\/doi.org\/10.18632\/aging.103215","DOI":"10.18632\/aging.103215"},{"key":"999_CR155","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.2147\/JIR.S317672","volume":"14","author":"R Zheng","year":"2021","unstructured":"Zheng R, Ruan Y, Yan Y et al (2021) Melatonin Attenuates Neuroinflammation by Down-Regulating NLRP3 Inflammasome via a SIRT1-Dependent Pathway in MPTP-Induced Models of Parkinson\u2019s Disease. J Inflamm Res 14:3063\u20133075. https:\/\/doi.org\/10.2147\/JIR.S317672","journal-title":"J Inflamm Res"},{"key":"999_CR156","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.it.2017.02.006","volume":"38","author":"C Zhong","year":"2017","unstructured":"Zhong C, Zhu J (2017) Small-Molecule ROR\u03b3t Antagonists: One Stone Kills Two Birds. Trends Immunol 38:229\u2013231. https:\/\/doi.org\/10.1016\/j.it.2017.02.006","journal-title":"Trends Immunol"},{"key":"999_CR157","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Lu M, Du R-H et al (2016) MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegener 11:28. https:\/\/doi.org\/10.1186\/s13024-016-0094-3","journal-title":"Mol Neurodegener"},{"key":"999_CR158","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10072-016-2808-2","volume":"38","author":"Z-H Zhou","year":"2017","unstructured":"Zhou Z-H, Wu Y-F, Wang X, Han Y-Z (2017) The c-Abl inhibitor in Parkinson disease. Neurol Sci 38:547\u2013552. https:\/\/doi.org\/10.1007\/s10072-016-2808-2","journal-title":"Neurol Sci"},{"key":"999_CR159","doi-asserted-by":"publisher","unstructured":"Zhou Y, Yamamura Y, Ogawa M et al (2018) c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism. Front Pharmacol 9. https:\/\/doi.org\/10.3389\/fphar.2018.01311","DOI":"10.3389\/fphar.2018.01311"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-00999-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-022-00999-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-00999-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T06:38:49Z","timestamp":1727159929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-022-00999-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":159,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1007\/s11011-022-00999-2","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable (Review article).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not Applicable (Review article).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable (Review article).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}